For short-term storage (under 3 months), maintain a temperature of 2C to 8C
By exploiting lipid peroxidation and iron metabolism dysregulation, ferroptosis provides a mechanism to eliminate therapy-resistant glioblastoma cells while minimizing reliance on immune system activation
Ingredients: water, L-carnitine, pantothenic acid (D-pantothenate, calcium), acids (E330, E296), flavouring, sweeteners (acesulfame K, sucralose, neotame, steviol glycosides from Stevia), preservatives (potassium sorbate, sodium benzoate), colour (E129), maltodextrin

Disclosures: ATSUSHI UMEDA: EA Pharma Co., Ltd.: Employee, YASUKO OWADA: Nothing to Disclose, KENICHI FURIHATA: Kissei Pharmaceutical Company: Advisor, SHUICHI TSURUOKA: Nothing to Disclose, Atsushi Nakajima: Nothing to Disclose, RYOSUKE MIKAMI: Nothing to Disclose, MASAKAZE OAKU: Nothing to Disclose, TAKUYA YAMAMOTO: Nothing to Disclose, TETSUO YANO: Nothing to Disclose, YUJI KUMAGAI: Nothing to Disclose 593 DNA METHYLOME ANALYSIS REVEALS EPIGENETIC ALTERATION OF COMPLEMENT GENES IN ADVANCED MASLD Won Kim 1 Young Ho So 1 YONG JIN JUNG 1 Sae Kyung Joo 1 , 1 Boramae Medical Center Background: Blocking the complement system presents a promising strategy to impede the progression of metabolic dysfunction-associated steatotic liver disease (MASLD)